The legalization of CBD-infused hemp products in the U.S. markets has opened doors for the explosive CBD oil-infused beverages market. This emerging market and touted as the next big thing and will have a value of $2.8 Billion in the next 4 years. Many cannabis companies will cash in on the opportunity, allowing investors to profit. But what are the top 5 cannabis beverage stocks for 2021?
Related: Global CBD-Infused Beverages Market Share Up by 27.5% CAGR
Cannabis beverages will be the most consumable form of hemp-derived cannabidiol extract for the foreseeable future. In other health and wellness applications, such as skin care, pain relief, and topical creams, CBD has already received recognition. In 2021, consumers will continue to have access to a growing variety of CBD infused energy drinks, tonic water, herbal teas, coffee, cocktails, kombuchas, and also sports nutrition drinks.
The Explosive Cannabis Beverage Market
CBD, the non-psychoactive derivative of the cannabis plant, doesn’t induce a high-effect but it has numerous health benefits.As CBD is typically available in the oil form (therefore hydrophobic), it is difficult to mix it directly into a beverage. The players involved in manufacturing the CBD-infused beverages use nanotechnology to break the oil in particles and increase its solvency.
Related: Entourage Health Partners with Boston Beer Subsidiary
According to the Brightfield Group, the global CBD-Hemp market will be worth $22 billion by 2022. Also, the ‘Disrupting Drinks’ reportby the Prohibition Partners predicts the cannabis-infused drinks will grow to approximately $4 billion by 2024. While there’s a debate on the total value of this market, the upside for cannabis investors is abundantly clear.
This includes beverages with CBD or THC (the psychoactive compound). It seems consumers are ready to break the stereotypes and are more than willing to taste these new age beverages. A study by A.T. Kearneyrevealed that 30% of the Americans are willing to go for non-alcoholic cannabis-infused beverages.
What are the top 5 cannabis beverage stocks for 2021? Let’s take a closer look.
#1 Canopy Growth
The largest cannabis company in the world in terms of production capacity, Canopy Growth (NYSE: CGC) has set its eyes on CBD-beverages as a pillar of growth. It has also joined forces with Constellation Brands, the leader in alcoholic beverages. In May, Constellation Brands, increased its stake in Canopy to 38.6%, through its subsidiary Greenstar Canada Investment.
The deal is worth $ 174 million, and the message is loud and clear. Canopy is betting immensely on CBD-beverages. Its CEO David Klein stated that it was set to double its capacity for Cannabis Beverage in August and is quite optimistic about making a mark in the U.S. cannabis market through its BioSteel sports drink.
To strengthen its commercial hemp farming logistics, Canopy Growth has also announced an investment in the range of US$100 million to US$150 million in New York for establishing a “Hemp Industrial Park”.
#2 Tilray
One of the renowned names in the research, production, and distribution of cannabinoids and cannabis, Tilray (NASDAQ: TLRY) is set to make it big in the CBD-infused beverage market. The hemp stock has partnered with Anheuser-Busch InBev, the single largest brewer globally, to produce non-alcoholic, cannabis-infused beverages. Tilray has also revamped its leadership team with those who have previous experience in top beverage companies.
Related: Organic Soft Drinks Market Trends Include CBD-Infusion, Zero Calorie, And Other Product Innovations
In a major development, the company also announced the acquisition of Manitoba Harvest, globally the largest vertically-integrated hemp edible producer, in early 2021. This acquisition will pave the way for Tilray to enter the CBD health and wellness market and make a mark in the beverages segment.
#3 Hexo Corp
Hexo (NYSE: HEXO) is a big name in Canadian consumer-packaged cannabis space which has over 1.3 million sq. ft. of facilities in Ontario and Quebec. In 2018, the hemp stock announced a joint-venture with a subsidiary of Molson Coors Brewing Company to develop non-alcoholic, cannabis-infused beverages. The joint venture is called Truss in which Molson Coors has a 57.5% controlling interest.
Related: Cannabis Drinks Expo Network Announces Multiple Events
In August, Truss Beverage launched 5 cannabis beverage brands namely Little Victory, House of Terpenes, Mollo, Veryvell, and XMG. These beverages have a variety of THC and CBD products with natural flavors. Truss plans to introduce the largest cannabis beverage portfolio to the Canadian market. The new cannabis beverages have been well-received by the consumers and are believed to give a boost to Hexo stock.
#4 New Age Beverages
New Age Beverages (NASDAQ: NBEV) is a company that has an early mover advantage in the CBD beverage space. In January 2018, the company announced the production and distribution of the Marley+CBD drinks product line. The Marley drinks portfolio sold CBD-infused relaxation teas with unique flavors like peach raspberry, lemon raspberry, and herbal honey.
New Age is amongst the largest non-alcoholic beverage companies in the world. It aims to be a market leader in this segment and has many healthy beverages besides the Marley Line. These include Búcha Live Kombucha, XingTea, Coco-Libre, TeMana, and others.
Related: 3 Best Cannabis Beverage Stocks to Buy 2021
In 2019, New Age Beverages further expanded its portfolio of Noni+Collagen products, a healthy beverage based on the Tahitian Noni fruit juice. New Age is constantly on the lookout for growth opportunities for its wellness-oriented beverages and continues to add unique elements to it. It is quite likely that New Age would also come up with CBD-infused Noni-Juice too.
#5 Phivida Holdings
Phivida (OTC: PHVAF) is a food and beverage company that specializes in wellness products and premium beverages infused with CBD-hemp. Its Oki-hemp-infused drinks are sold in more than 100 stores across Colorado. The Oki drinks offer iced teas and waters with active hemp extract.
In November 2019, the hemp company also entered into an agreement with a single distributor to handle the merchandise and sales of its Oki beverages in Florida. Oki is available in eight unique flavors and is sold in six US states besides Florida. The brand is immensely successful and it has seen more than 200% distribution growth in the last months of 2019.
The Bottom Line
Cannabis-infused beverages have a promising future ahead. Sensing a huge opportunity, most big players are foraying into this Cannabis 2.0 space. With the legalization of recreational marijuana still elusive in the US, there are sure to be initial challenges.
However, once key regulatory aspects are sorted out, the CBD-beverage market will attract multiple players. Many cannabis companies will cash in on the opportunity, allowing investors to profit which is why cannabis investors should consider watching these top 5 cannabis beverage stocks.
Top 5 Cannabis Beverage Stocks for 2021
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
Related posts:
FAQs
What is the best cannabis company to invest in stocks? ›
- Marijuana stocks could catch fire in 2022. ...
- Curaleaf Holdings Inc. ( ...
- Green Thumb Industries Inc. ( ...
- Trulieve Cannabis Corp. ( ...
- Cresco Labs Inc. ( ...
- WM Technology Inc. ( ...
- Irwin Naturals Inc. ( ...
- Aurora Cannabis Inc. (
Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency, ETFs, and alternative investments on Investopedia since 2016. Nasdaq-listed marijuana companies include Tilray Brands Inc., Organigram Holdings Inc., and GrowGeneration Corp.
Should I buy Cresco Labs stock? ›Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
What is the best to invest in right now? ›- High-yield savings accounts.
- Certificates of deposit (CDs)
- Money market funds.
- Government bonds.
- Corporate bonds.
- Mutual funds.
- Index funds.
- Exchange-traded funds (ETFs)
Tilray Brands, Inc.
may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of TLRY, demonstrate its potential to underperform the market.
...
- Green Thumb Industries. ...
- Cresco Labs. ...
- Innovative Industrial Properties. ...
- GrowGeneration. ...
- ScottsMiracle-Gro. ...
- Jazz Pharmaceuticals.
- Ayr Wellness Inc. (OTC:AYRWF) Number of Hedge Fund Holders: N/A. ...
- Trulieve Cannabis Corp. (OTC:TCNNF) ...
- Jushi Holdings Inc. (OTC:JUSHF) ...
- Verano Holdings Corp. (OTC:VRNOF) ...
- Green Thumb Industries Inc. (OTC:GTBIF) ...
- Curaleaf Holdings Inc. (OTC:CURLF) ...
- Cresco Labs Inc. (OTC:CRLBF)
Stock Price Forecast
The 16 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 7.57, with a high estimate of 17.95 and a low estimate of 3.58. The median estimate represents a +120.74% increase from the last price of 3.43.
USD 3.05 0.02 0.65% Assuming the 90 days horizon and your below-average risk tolerance, our recommendation regarding Cresco Labs is 'Strong Sell'.
Why does Cresco keep dropping? ›Cresco Labs stock is dropping due to a shift from growth stocks. Cresco Labs stock has fallen 36 percent from its peak. One of the reasons is the overall drop in marijuana and growth stocks due to the rotation in equity markets from growth to value. The soaring valuations have led to pressure on marijuana stocks.
Which is best share to buy in 2022? ›
| Company name | Current share price |
|---|---|
| Reliance Industries Ltd | ₹2433 |
| Metropolis Healthcare Ltd | ₹1567 |
| Balaji Amines Ltd | ₹3236 |
| Infosys Ltd | ₹1451 |
- 1) Reliance Industries. ...
- 2) Tata Consultancy Services (TCS) ...
- 3) Infosys. ...
- 4) HDFC Bank. ...
- 5) Hindustan Unilever.
- High-yield savings accounts. ...
- Series I savings bonds. ...
- Short-term certificates of deposit. ...
- Money market funds. ...
- Treasury bills, notes, bonds and TIPS. ...
- Corporate bonds. ...
- Dividend-paying stocks. ...
- Preferred stocks.
Stock Price Forecast
The 16 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 3.88, with a high estimate of 9.30 and a low estimate of 2.00. The median estimate represents a +6.90% increase from the last price of 3.63.
When the market matures, Tilray might be expensive. It is not too late for long-term investors to get a small stake in Tilray right now. However, keep in mind that marijuana investments are risky. Hence, it is wise to diversify your portfolio with high-quality stocks from several sectors.
Is Tilray a buy 2022? ›Tilray Brands (TLRY -18.72%) is having a rough time. Shares of the Canadian cannabis juggernaut have declined by 44.8% since the start of 2022. And per its latest earnings report for its 2022 fiscal year, published July 28, investors should expect the bumpy ride to continue, at least for another quarter or so.
Is Curaleaf a good stock to buy? ›10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CURLF shares.
Is Aurora a buy? ›The technical analysis of the Aurora Cannabis share price shows short-term buy signals but longer term sell signals with the following chart indicators: The RSI is currently at 33.431, which sends a strong buy signal on this stock.
Is Green Thumb Industries a buy? ›Green Thumb Industries has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.
Is the hemp industry a good investment? ›Additionally, sales of hemp-based products are expected to reach $2.61 billion by 2022, based on data provided by Statista. The above serves to prove that the hemp industry is set to become a highly lucrative investment opportunity, with companies like Altria Group, Inc. (NYSE:MO), Philip Morris International Inc.
Should I invest in hemp? ›
Investing in hemp is a much safer option for cannabis investors, who may be concerned about the lack of nationwide legality of marijuana in the U.S. and the impact it could have on the industry's growth. Although over the long term, the marijuana market may explode in size, that's still a long way from happening.
What company produces the most hemp? ›...
Some of the company's offerings include:
- Market Research.
- Plant setup.
- Plant Expansion.
- Marketing and sales.
- Procurement and Distribution.
- Innovation and Product Development.
Stock Price Forecast
The 19 analysts offering 12-month price forecasts for Trulieve Cannabis Corp have a median target of 27.67, with a high estimate of 54.00 and a low estimate of 15.35. The median estimate represents a +156.23% increase from the last price of 10.80.
In March 2022, Cresco Labs announced the acquisition of New York-based cannabis firm, Columbia Care, for $2 billion in an all-stock transaction. Following this acquisition, Cresco will have the second-largest retail footprint in the industry after Trulieve.
Is Cresco Labs making money? ›The best news for Cresco was that its retail revenue jumped 22% year over year to $123 million. Same-store sales rose 6%. Both numbers were higher than the company's overall revenue growth of 4%.
Is Flex stock a buy? ›The Flextronics International Ltd. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
Is Curlf a buy or sell? ›According to the issued ratings of 10 analysts in the last year, the consensus rating for Curaleaf stock is Moderate Buy based on the current 2 hold ratings and 8 buy ratings for CURLF. The average twelve-month price prediction for Curaleaf is $13.79 with a high price target of $16.00 and a low price target of $10.00.
How do I invest in Cresco labs? ›Cresco stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors.
Is Columbia care a good stock to buy? ›The Columbia Care Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
Can I buy Cresco Labs stock on Robinhood? ›Is Cresco Labs on Robinhood? Cresco Labs isn't a stock that Robinhood retail investors will be able to invest in. Robinhood doesn't permit the trading of OTC stocks on its platform. So, someone who wants to invest in Cresco will need to open an account with a brokerage that allows OTC trading.
Is Cresco Labs an American company? ›
Company Brief
Cresco Labs (CSE: CL) (OTCQX: CRLBF), based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy.
- Ayr Wellness Inc. (OTC:AYRWF) Number of Hedge Fund Holders: N/A. ...
- Trulieve Cannabis Corp. (OTC:TCNNF) ...
- Jushi Holdings Inc. (OTC:JUSHF) ...
- Verano Holdings Corp. (OTC:VRNOF) ...
- Green Thumb Industries Inc. (OTC:GTBIF) ...
- Curaleaf Holdings Inc. (OTC:CURLF) ...
- Cresco Labs Inc. (OTC:CRLBF)
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CURLF shares.
How high can Cresco Labs stock go? ›Stock Price Forecast
The 17 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 7.37, with a high estimate of 17.95 and a low estimate of 3.45. The median estimate represents a +141.67% increase from the last price of 3.05.
Valuation metrics show that Green Thumb Industries Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of GTBIF, demonstrate its potential to outperform the market.
Is the hemp industry a good investment? ›Additionally, sales of hemp-based products are expected to reach $2.61 billion by 2022, based on data provided by Statista. The above serves to prove that the hemp industry is set to become a highly lucrative investment opportunity, with companies like Altria Group, Inc. (NYSE:MO), Philip Morris International Inc.
Is Aurora a buy? ›The technical analysis of the Aurora Cannabis share price shows short-term buy signals but longer term sell signals with the following chart indicators: The RSI is currently at 33.431, which sends a strong buy signal on this stock.
Should I invest in hemp? ›Investing in hemp is a much safer option for cannabis investors, who may be concerned about the lack of nationwide legality of marijuana in the U.S. and the impact it could have on the industry's growth. Although over the long term, the marijuana market may explode in size, that's still a long way from happening.
Is Curaleaf a Buy Sell or Hold? ›According to the issued ratings of 10 analysts in the last year, the consensus rating for Curaleaf stock is Moderate Buy based on the current 2 hold ratings and 8 buy ratings for CURLF. The average twelve-month price prediction for Curaleaf is $13.79 with a high price target of $16.00 and a low price target of $10.00.
What is the future of Curaleaf stock? ›Stock Price Forecast
The 17 analysts offering 12-month price forecasts for Curaleaf Holdings Inc have a median target of 9.32, with a high estimate of 14.89 and a low estimate of 7.00. The median estimate represents a +73.54% increase from the last price of 5.37.
What is the future of Curaleaf? ›
Industry experts predict close to seven states could legalize marijuana in 2022. The company already has a presence in 23 U.S. states. Curaleaf can also take advantage of its presence in the burgeoning European market, which could grow at a compound annual rate of 29.6% through 2027 to $37 billion.
Why does Cresco keep dropping? ›Cresco Labs stock is dropping due to a shift from growth stocks. Cresco Labs stock has fallen 36 percent from its peak. One of the reasons is the overall drop in marijuana and growth stocks due to the rotation in equity markets from growth to value. The soaring valuations have led to pressure on marijuana stocks.
What is the target price for Trulieve? ›Stock Price Forecast
The 19 analysts offering 12-month price forecasts for Trulieve Cannabis Corp have a median target of 27.67, with a high estimate of 54.00 and a low estimate of 15.35. The median estimate represents a +156.23% increase from the last price of 10.80.
In March 2022, Cresco Labs announced the acquisition of New York-based cannabis firm, Columbia Care, for $2 billion in an all-stock transaction. Following this acquisition, Cresco will have the second-largest retail footprint in the industry after Trulieve.
Why is Green Thumb Industries stock falling? ›The failure of legalization bills to advance through Congress has weighed on U.S. operators like Green Thumb. Its stock has dropped about 55% this year, in line with the industry tracking AdvisorShares Pure US Cannabis exchange-traded fund (MSOS), but well worse than the 20% decline of the Nasdaq Composite index.
Should I sell my green thumb stock? ›Green Thumb Industries has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.
Is Trulieve a buy right now? ›5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TCNNF shares. View TCNNF analyst ratings or view top-rated stocks.